News

Featured in

In the media

Analysts see $400B BCI opportunity

MassDevice

October 11, 2024

United States sets the pace for implantable brain–computer interfaces

Nature

October 2, 2024

Inside Paradromics, the Neuralink competitor hoping to commercialize brain implants before the end of the decade

CNBC

June 19, 2024

What You Need to Know About Brain-Computer Interfaces

Forbes

May 10, 2024

Elon Musk wants more bandwidth between people and machines. Do we need it?

MIT Technology Review

September 29, 2023

For brain-computer interfaces, the commercial hurdles may be bigger than scientific ones

STAT

August 4, 2023

Elon Musk's brain tech firm Neuralink approved for human trials, Austin's Paradromics close behind

Austin American-Statesman

June 1, 2023

Neuralink competitor Paradromics gets one step closer to FDA approval for its brain implant

CNBC

May 18, 2023

Company News

Paradromics Accepted to FDA Regulatory Accelerator Program and Announces New Patient Registry

Paradromics CEO Matt Angle on the Neuralink Demo

Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA

The Neurotech Revolution goes (back) to Washington!

Paradromics CEO Matt Angle at NANS 2023

The Neurotech Revolution goes to Washington!

Paradromics Announces Neurotech Track at Built with Biology 2022

Paradromics Announces NIH Award to Fund Translational and Early-Stage Clinical Research

Paradromics Raises $20MM in Seed Funding Led by Prime Movers Lab to Advance Brain Computer Interfaces

Paradromics Develops Precision Laser Surgical Tool that can be Used to Aid BCI Implantation

Paradromics Featured on Loup Ventures’ Neurotech podcast

4030 W Braker Ln Ste 250
Austin TX 78759
512-559-4120